Home » Topics » BioWorld Science

BioWorld Science
RSS

Crinetics Pharmaceuticals identifies somatostatin SST5 receptor agonists

Sep. 3, 2019

TREM2 correlates with slow decline in AD

Sep. 3, 2019

Daiichi Sankyo presents new analgesics

Sep. 3, 2019

HIV rebound shows diverse sources, identical virus

Sep. 3, 2019

KBP Biosciences patents new bacterial LpxC inhibitors

Sep. 3, 2019

UCn2 gene transfer improves diabetes-related left-ventricular dysfunction in mice

Sep. 3, 2019

Eicosis' soluble epoxide hydrolase inhibitor EC-5026 to enter the clinic

Sep. 3, 2019

Lower affinity means lower affinity, but higher persistence, for CAR T cells

Sep. 3, 2019

Alcohol consumption is deceased with FGFR1 inhibition in rodents

Sep. 3, 2019

First preclinical data presented on miR-132 inhibitor CDR132L in heart failure model

Sep. 3, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.